Through a comprehensive approach combining large-scale clinical data analysis, in vitro functional assays, and an in vivo xenograft model, we demonstrate that a FTO-EREG-PI3K/Akt signaling axis plays a pivotal role in controlling glioma proliferation. Here, EREG is linked to central nervous system cancer.